Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease
Candida Manelfi, Jonas Goßen, Silvia Gervasoni, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 797-797
Open Access | Times Cited: 18

Showing 18 citing articles:

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 54
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities
Angela Corona, Krzysztof Wycisk, Carmine Talarico, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 4, pp. 226-239
Open Access | Times Cited: 54
Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening
Clara Blanes‐Mira, Pilar Fernández-Aguado, Jorge de Andrés-López, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 175-175
Open Access | Times Cited: 39
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
Matteo Pavan, Stefano Moro
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4401-4401
Open Access | Times Cited: 13
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
Daniela Iaconis, Licia Bordi, Giulia Matusali, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 14
Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis
Juan Wang, Ge Wen, Xin Peng, et al.
Molecular Diversity (2021) Vol. 26, Iss. 2, pp. 1175-1190
Open Access | Times Cited: 17
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication
Angela Corona, Valentina Noemi Madia, Riccardo De Santis, et al.
Antiviral Research (2023) Vol. 217, pp. 105697-105697
Open Access | Times Cited: 6
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Marco Tutone, Anna Maria Almerico
Molecules (2021) Vol. 26, Iss. 24, pp. 7500-7500
Open Access | Times Cited: 15
The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses
Оlga I. Yarovaya, Aleksandr S. Filimonov, Dmitry S. Baev, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 215-215
Open Access | Times Cited: 1
Virus structure and structure-based antivirals
Z Plavec, Ina Pöhner, Antti Poso, et al.
Current Opinion in Virology (2021) Vol. 51, pp. 16-24
Open Access | Times Cited: 12
Ensemble of structure and ligand-based classification models for hERG liability profiling
Serena Vittorio, Filippo Lunghini, Alessandro Pedretti, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Are protein–ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?
Ariadna Llop-Peiró, Guillem Macip, Santiago Garcı́a-Vallvé, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 10, pp. 104137-104137
Open Access
Approaching Pharmacological Space: Events and Components
Giulio Vistoli, Carmine Talarico, Serena Vittorio, et al.
Methods in molecular biology (2024), pp. 151-169
Closed Access
Extensive Sampling of Molecular Dynamics Simulations to Identify Reliable Protein Structures for Optimized Virtual Screening Studies: The Case of the hTRPM8 Channel
Silvia Gervasoni, Carmine Talarico, Candida Manelfi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7558-7558
Open Access | Times Cited: 3
Exscalate4CoV: Innovative High Performing Computing (HPC) Strategies to Tackle Pandemic Crisis
Andrea R. Beccari, Giulio Vistoli
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11576-11576
Open Access | Times Cited: 2
A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors
Babak Sokouti
Exploration of Targeted Anti-tumor Therapy (2023), pp. 994-1026
Open Access
Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants
Daniela Iaconis, Carmine Talarico, Candida Manelfi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Marco Tutone, Anna Maria Almerico
MDPI eBooks (2021)
Open Access
Page 1

Scroll to top